160 related articles for article (PubMed ID: 26754533)
1. The leukemic oncoprotein NPM1-RARA inhibits TP53 activity.
Swaney EM; Chattopadhyay A; Abecassis I; Rush EA; Redner RL
Leuk Lymphoma; 2016 Aug; 57(8):1933-7. PubMed ID: 26754533
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel TNRC18-RARA fusion in acute promyelocytic leukemia lacking t(15;17)(q24;q12)/PML-RARA.
Wang Z; Wen L; Zhang L; Xu X; Chen X; Yao L; Wang M; Shen Z; Mo G; Wang Y; Zhao D; Cai W; Shen J; Chi X; Xu Y; Zeng Z; Pan J; Ruan C; Wu D; Jia Z; Chen S
Mol Carcinog; 2021 Feb; 60(2):. PubMed ID: 33428799
[TBL] [Abstract][Full Text] [Related]
3. FNDC3B is another novel partner fused to RARA in the t(3;17)(q26;q21) variant of acute promyelocytic leukemia.
Cheng CK; Wang AZ; Wong THY; Wan TSK; Cheung JS; Raghupathy R; Chan NPH; Ng MHL
Blood; 2017 May; 129(19):2705-2709. PubMed ID: 28314734
[No Abstract] [Full Text] [Related]
4. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion.
Redner RL; Rush EA; Faas S; Rudert WA; Corey SJ
Blood; 1996 Feb; 87(3):882-6. PubMed ID: 8562957
[TBL] [Abstract][Full Text] [Related]
5. NPM-RAR, not the RAR-NPM reciprocal t(5;17)(q35;q21) acute promyelocytic leukemia fusion protein, inhibits myeloid differentiation.
Pollock SL; Rush EA; Redner RL
Leuk Lymphoma; 2014 Jun; 55(6):1383-7. PubMed ID: 23927396
[TBL] [Abstract][Full Text] [Related]
6. A new transcriptional variant and small azurophilic granules in an acute promyelocytic leukemia case with NPM1/RARA fusion gene.
Kikuma T; Nakamachi Y; Noguchi Y; Okazaki Y; Shimomura D; Yakushijin K; Yamamoto K; Matsuoka H; Minami H; Itoh T; Kawano S
Int J Hematol; 2015 Dec; 102(6):713-8. PubMed ID: 26342691
[TBL] [Abstract][Full Text] [Related]
7. BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia.
Yamamoto Y; Tsuzuki S; Tsuzuki M; Handa K; Inaguma Y; Emi N
Blood; 2010 Nov; 116(20):4274-83. PubMed ID: 20807888
[TBL] [Abstract][Full Text] [Related]
8. Extrinsic apoptosis is impeded by direct binding of the APL fusion protein NPM-RAR to TRADD.
Chattopadhyay A; Hood BL; Conrads TP; Redner RL
Mol Cancer Res; 2014 Sep; 12(9):1283-91. PubMed ID: 25033841
[TBL] [Abstract][Full Text] [Related]
9. Recurrent
Osumi T; Tsujimoto SI; Tamura M; Uchiyama M; Nakabayashi K; Okamura K; Yoshida M; Tomizawa D; Watanabe A; Takahashi H; Hori T; Yamamoto S; Hamamoto K; Migita M; Ogata-Kawata H; Uchiyama T; Kizawa H; Ueno-Yokohata H; Shirai R; Seki M; Ohki K; Takita J; Inukai T; Ogawa S; Kitamura T; Matsumoto K; Hata K; Kiyokawa N; Goyama S; Kato M
Cancer Res; 2018 Aug; 78(16):4452-4458. PubMed ID: 29921692
[TBL] [Abstract][Full Text] [Related]
10. IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid.
Mazharuddin S; Chattopadhyay A; Levy MY; Redner RL
Leuk Lymphoma; 2018 Sep; 59(9):2246-2249. PubMed ID: 29350080
[No Abstract] [Full Text] [Related]
11. Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia.
Fabiani E; Cicconi L; Nardozza AM; Cristiano A; Rossi M; Ottone T; Falconi G; Divona M; Testi AM; Annibali O; Castelli R; Lazarevic V; Rego E; Montesinos P; Esteve J; Venditti A; Della Porta M; Arcese W; Lo-Coco F; Voso MT
Cancer Med; 2021 Jun; 10(12):3839-3847. PubMed ID: 34042280
[TBL] [Abstract][Full Text] [Related]
12. Acute promyelocytic leukaemia (APML) with cryptic PML-RARA fusion has a clinical course comparable to classical APML with t(15;17)(q24.1;q21.2) translocation.
Greenfield G; Michail O; Merron B; McGimpsey J; Catherwood M; McMullin MF
Br J Haematol; 2019 Jul; 186(1):155-157. PubMed ID: 30585303
[No Abstract] [Full Text] [Related]
13. Identification of novel recurrent
Yao L; Wen L; Wang N; Liu T; Xu Y; Ruan C; Wu D; Chen S
Blood; 2018 Feb; 131(8):935-939. PubMed ID: 29237593
[No Abstract] [Full Text] [Related]
14. The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia.
Zhao J; Liang JW; Xue HL; Shen SH; Chen J; Tang YJ; Yu LS; Liang HH; Gu LJ; Tang JY; Li BS
Leukemia; 2019 Jun; 33(6):1387-1399. PubMed ID: 30575821
[TBL] [Abstract][Full Text] [Related]
15. Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia.
Lee GY; Christina S; Tien SL; Ghafar AB; Hwang W; Lim LC; Lim TH
Cancer Genet Cytogenet; 2005 Jun; 159(2):129-36. PubMed ID: 15899384
[TBL] [Abstract][Full Text] [Related]
16. Acute promyelocytic leukemia in early pregnancy with translocation t(15;17) and variant PML/RARA fusion transcripts.
Park TS; Lee ST; Kim JS; Song J; Lee KA; Kim SJ; Seok YM; Lee HJ; Han JH; Kim JK; Lee EY; Choi JR
Cancer Genet Cytogenet; 2009 Jan; 188(1):48-51. PubMed ID: 19061780
[TBL] [Abstract][Full Text] [Related]
17. Report of IRF2BP1 as a novel partner of RARA in variant acute promyelocytic leukemia.
Jiang M; Wang X; Yu M; Jiang S; Hong M; Zhou Y; Li F; Liu H; Zhang Z
Am J Hematol; 2024 May; 99(5):1005-1007. PubMed ID: 38410879
[TBL] [Abstract][Full Text] [Related]
18. The rare IRF2BP2-RARA fusion in acute promyelocytic leukemia.
Yang X; Zhang R; Zhang Z
Ann Hematol; 2022 Sep; 101(9):2101-2102. PubMed ID: 35704083
[No Abstract] [Full Text] [Related]
19. The cryptic IRF2BP2-RARA fusion transforms hematopoietic stem/progenitor cells and induces retinoid-sensitive acute promyelocytic leukemia.
Jovanovic JV; Chillón MC; Vincent-Fabert C; Dillon R; Voisset E; Gutiérrez NC; Sanz RG; Lopez AA; Morgan YG; Lok J; Solomon E; Duprez E; Díaz MG; Grimwade D
Leukemia; 2017 Mar; 31(3):747-751. PubMed ID: 27872498
[No Abstract] [Full Text] [Related]
20. PML-RARA-RXR oligomers mediate retinoid and rexinoid/cAMP cross-talk in acute promyelocytic leukemia cell differentiation.
Kamashev D; Vitoux D; De Thé H
J Exp Med; 2004 Apr; 199(8):1163-74. PubMed ID: 15096541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
